Cervical and Ocular Vestibular-Evoked Myogenic Potentials in Patients With Intracochlear Schwannomas by Fröhlich, Laura et al.
ORIGINAL RESEARCH
published: 27 October 2020
doi: 10.3389/fneur.2020.549817
Frontiers in Neurology | www.frontiersin.org 1 October 2020 | Volume 11 | Article 549817
Edited by:
P. Ashley Wackym,




Massachusetts Eye & Ear Infirmary
and Harvard Medical School,
United States
Denise Utsch Gonçalves,






This article was submitted to
Neuro-Otology,
a section of the journal
Frontiers in Neurology
Received: 07 April 2020
Accepted: 22 September 2020
Published: 27 October 2020
Citation:
Fröhlich L, Curthoys IS, Kösling S,
Obrist D, Rahne T and Plontke SK
(2020) Cervical and Ocular
Vestibular-Evoked Myogenic






Potentials in Patients With
Intracochlear Schwannomas
Laura Fröhlich 1*, Ian S. Curthoys 2, Sabrina Kösling 3, Dominik Obrist 4, Torsten Rahne 1 and
Stefan K. Plontke 1
1Department of Otorhinolaryngology, Head and Neck Surgery, Martin Luther University Halle-Wittenberg, Halle (Saale),
Germany, 2 Vestibular Research Laboratory, School of Psychology, The University of Sydney, Sydney, NSW, Australia,
3Department of Radiology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany, 4 ARTORG Center for
Biomedical Engineering Research, University of Bern, Bern, Switzerland
Objective: To evaluate ocular and cervical vestibular evoked myogenic potentials
(oVEMPs and cVEMPs) in patients with solely intracochlear localization of an
intralabyrinthine schwannoma (ILS).
Study Design: Retrospective analysis of a series of cases.
Setting: Monocentric study at a tertiary referral center.
Patients: Patients with intracochlear schwannoma (ICS) and VEMP measurements.
Outcome Measures: Signed asymmetry ratio (AR) of cVEMPs and oVEMPs to air
conducted sound with AR cut-offs considered to be asymmetrical when exceeding
±30% for cVEMPs and ±40% for oVEMPs with respect to the side affected by the
tumor (reduced amplitudes on the affected side indicated by negative values, enhanced
amplitudes by positive values); VEMP amplitudes and latencies; tumor localization in the
cochlear turn and scala.
Results: Nineteen patients with a solely intracochlear tumor (ICS patients) [10 males, 9
females, mean age 57.1 (SD: 13.4) years] were included in the study. On the affected
side, cVEMPs were absent or reduced in 47% of the patients, normal in 32%, and
enhanced in 21%. Ocular VEMPs on the affected side were absent or reduced in 53% of
the patients, normal in 32% and enhanced in 15%. Latencies for cVEMPs and oVEMPs
were not significantly different between the affected and non-affected side. In all patients
with enhanced VEMPs, the tumor was located in the scala tympani and scala vestibuli.
Conclusions: As a new and unexpected finding, VEMP amplitudes can be enhanced in
patients with intracochlear schwannoma, mimicking the third window syndrome.
Keywords: third window, vestibular schwannoma, intralabyrinthine, intracochlear, VEMP, asymmetry, secondary
hydrops, semicircular canal dehiscence
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INTRODUCTION
It was observed that intralabyrinthine schwannomas (ILS) can
mimic various common cochleovestibular diseases in their
symptoms and findings in functional tests. Cochleovestibular
schwannomas in general, often also referred to as vestibular
schwannomas or acoustic neuromas, are benign tumors that
arise from the Schwann cells of the eighth cranial nerve. The
schwannomas are referred to as ILS, when they arise from
the most peripheral branches of the cochlear or vestibular
nerves, i.e., inside the membranous labyrinth (1). ILS can
present e.g., with sudden, progressive, or fluctuating hearing
loss, pseudo-conductive hearing loss, and/or vertigo, and/or
(pulsating) tinnitus, and have been misdiagnosed e.g., as
Menière’s disease (MD) or sudden hearing loss (2–8). The
diagnosis is based on high-resolution magnetic resonance
imaging (MRI). Various slightly differing classifications
of these tumors have been suggested in the literature
(2, 5, 9). The most recent and detailed classification was
suggested by Van Abel et al. (5) distinguishing intracochlear,
intravestibular, intravestibulocochlear, transmodiolar,
transmacular, tympanolabyrinthine, translabyrinthine, and
transotic locations or extensions. An extension from the internal
auditory canal into the cerebellopontine angle is possible. Van
Abel et al. (5) have also described that vertigo and imbalance
were commonly reported when the tumors also extended to the
vestibular labyrinth but were only reported by 36% of patients
with intracochlear schwannomas (ICS). Intracochlear tumor
localization seems to be the most common in ILS (2, 9).
The recording of cervical and ocular vestibular evoked
myogenic potentials (cVEMPs, oVEMPs) has been described as
a screening tool for the assessment of nerve of origin in patients
with cochleovestibular schwannoma (10). However, only few
data are available on VEMPs in patients with an ILS. Lee et al.
(11) described absent or decreased cVEMPs and oVEMPs in
patients with ILS without specifying the exact tumor location.
Ralli et al. (12) reported an absent oVEMP in a patient with an
intravestibular ILS with presence of “a solid mass in the utricle”
confirmed by magnetic resonance imaging (MRI). Dubernard
et al. (6) analyzed cVEMPs in 36 (32%) of their reported 110
patients with ILS. Twelve patients had an intracochlear tumor
and cVEMPs were abnormal, i.e., absent or significantly reduced,
in 50% of these patients and preserved in the remaining 50%.
To date, there is no study in which both oVEMPs and cVEMPs
were systematically analyzed in a series of patients with solely
intracochlear tumors.
VEMPs have also been described to be highly sensitive to
changes in the inner ear fluid dynamics and to detect defects
of the bony labyrinthine wall. In 1998, Minor et al. (13) were
Abbreviations: ILS, intralabyrinthine schwannoma; MD, Menière’s disease; MRI,
magnetic resonance imaging; ICS, intracochlear schwannoma; cVEMP, cervical
vestibular evoked myogenic potential; oVEMP, ocular vestibular evoked myogenic
potential; SSCD, superior semicircular canal dehiscence; VEMP, vestibular evoked
myogenic potential; EMG, electromyogram; BT, basal turn; MT, middle turn; AT,
apical turn; ST, scala tympani; SV, scala vestibuli; CT, computed tomography;
AR, asymmetry ratio; AS, affected side; NAS, non-affected side; ICC, intraclass
correlation coefficient.
the first to report about patients with a defect in the bony wall
of the superior semicircular canals, a superior semicircular
canal dehiscence (SSCD). Over time, various conditions with a
defect of the labyrinthine bony wall have been described in the
literature (14–22). These are associated with a similar spectrum
of symptoms and objective findings so that these conditions
are now summarized under the general term of “third window
syndrome” or “third window abnormalities” (23, 24). Wackym
et al. (24) defined the following conditions associated with
the term of third window syndrome: “SSCD, cochlea-facial
nerve dehiscence, cochlea-internal carotid artery dehiscence,
cochlea-internal auditory canal dehiscence, lateral semicircular
canal-superior semicircular canal ampulla dehiscence, modiolus,
perilymph fistula, posterior semicircular canal dehiscence,
posterior semicircular canal-jugular bulb dehiscence, SSCD-
subarcuate artery dehiscence, SSCD-superior petrosal vein
dehiscence, vestibule-middle ear dehiscence, lateral semicircular
canal-facial nerve dehiscence, wide vestibular aqueduct
in children, post-traumatic hypermobile stapes footplate,
otosclerosis with internal auditory canal involvement.” The
objective findings of increased VEMP amplitudes and/or lower
VEMP thresholds have been reported in patients with SSCD
(25–28), posterior semicircular canal dehiscence (16, 29), large
vestibular aqueduct (30), perilymph fistula (31), cochlea-facial
nerve dehiscence (24), posterior semicircular canal-jugular bulb
dehiscence (32), and SSCD-superior petrosal vein dehiscence
(33). In these patients, the presence of a third window caused
by an otic capsule defect changed the mechanical properties,
i.e., the fluid dynamics, of the inner ear. It has been shown by
measurements and models, that in SSCD ears incoming acoustic
energy causes larger fluid displacement in the semicircular canals
(34–36). Furthermore, animal studies demonstrated that this
results in activation of semicircular canal neurons in addition
to otolith neurons (37). These canal afferents project to the
contralateral (external ocular) inferior oblique muscle as well
as the ipsilateral sternocleidomastoid muscle (inhibitory) and
thus their activity contributes to and enhances cVEMPs and
oVEMPs (38).
Apart from defects in the bony labyrinth, other inner ear
pathologies have the potential to impact inner ear mechanics.
Endolymphatic hydrops for instance, which can have various
causes (39, 40), is believed to have a huge impact on inner
fluid mechanics (41–43). This argument is supported by VEMP
studies in patients suffering from clinically diagnosed definite
MD. Asymmetric, enhanced cVEMPs (44, 45) but also enhanced
oVEMPs in MD patients have been reported (46, 47). These
inner ear pathologies can therefore mimic third window
syndrome with regard to VEMP test results. While ILS can
mimic other cochleovestibular diseases in their symptoms and
functional findings, it is unknown, if ILS can also mimic
third window syndrome as was described for other inner
ear pathologies.
The aim of this study was to review and describe oVEMPs and
cVEMPs of patients with solely intracochlear localization of an
ILS. By including only ICS patients, we sought to avoid those
with direct impact of the intravestibular schwannoma on otolith
organs which might lead to a change in VEMP results.
Frontiers in Neurology | www.frontiersin.org 2 October 2020 | Volume 11 | Article 549817
Fröhlich et al. Enhanced VEMPs to Intracochlear Schwannomas
MATERIALS AND METHODS
Study Design and Participants
In this retrospective analysis, patients of a single tertiary
referral center were included. In a personal case series
(SKP) at the University Hospital Halle of 53 consecutive
patients with intralabyrinthine schwannoma (ILS), magnetic
resonance images were analyzed for localization of the tumor.
Patients with solely intracochlear schwannoma (ICS) in whom
VEMP measurements had been performed between August
2015 and January 2020 were included in this study (ICS
patient group). Patients without VEMP measurements or with
other tumor localizations [see introduction according to Van
Abel et al. (5)] were excluded from this study to avoid
influence by direct impact of the tumor on the otoliths or by
retrocochlear pathology.
Written informed consent was obtained from all patients. The
study protocol was reviewed and approved by the responsible
institutional review board (ethics committee of the Medical
Faculty of Martin Luther University Halle-Wittenberg and the
University Hospital Halle, approval number: 2019-26), and
conducted according to the Declaration of Helsinki.
VEMP Testing
The VEMP tests of the included patients were reviewed. All
VEMP recordings were collected and analyzed using the Eclipse
recording platform (Interacoustics A/S, Middelfart, Denmark).
Self-adhesive Neuroline 720 surface electrodes (Ambu A/S,
Ballerup, Denmark) were used for electromyogram (EMG)
recording after the skin was prepared to provide impedances
of 5 k or less. For cVEMPs, the electrodes were placed over
the middle of the sternocleidomastoid muscle ipsilateral to the
stimulated ear and over the sternum. For oVEMP recordings,
the electrodes were placed on the infra-orbital ridge 1 cm below
the lower eyelid contralateral to the stimulated ear and about
2 cm below the first electrode. The ground electrode was always
positioned on the forehead.
During VEMP testing the patients were sitting on a chair.
They were asked to turn their head to the contralateral shoulder
for cVEMP testing and hold this position to achieve a constant
tonic activation of the sternocleidomastoid muscle (50–200 µV)
during the whole recording period. During data acquisition the
EMG was monitored and appropriate feedback was provided
in real time to ensure that sufficient muscular contraction was
sustained (48). For oVEMP testing, the patients were asked to
keep their head in a neutral position and look up, maintaining
an angle of 20–30◦.
For both, cVEMP, and oVEMP testing, air-conducted 500Hz
tone bursts (1 cycle rise/fall time, 2 cycles plateau) were
delivered by ER-3A insert earphones (3M, St. Paul, MS,
USA) at 100 dB nHL.
The EMG signals were recorded in a −20 to 80ms window
relative to the onset of the stimulus. A bandpass filter of 10–
1,000Hz was applied and the artifact rejection level was set to
400 µV. The responses were averaged to at least 200 stimuli and
at least two trials were recorded for each VEMP test.
Specifying Tumor Location
All patients underwent MRI of the temporal bone with at
least thin-sliced 3D T2-weighted and T1-weighetd images
with contrast medium. In all included patients, the MRI was
(retrospectively) systematically studied regarding the localization
of the tumor. The classification suggested by Van Abel et al. (5)
was used to classify tumor localization in the basal turn (BT),
middle turn (MT), or apical turn (AT) of the cochlea, including
combinations of these localizations. Additionally, localization of
the tumor in the scala tympani (ST) and/or scala vestibuli (SV)
was specified, if possible. The MRIs originated from different
sources, often from outside our hospital, and thus, showed
considerable differences in resolution. MRIs were not repeated,
if the scans were sufficient for establishing the diagnosis of ICS.
Exclusion of Third Window Syndromes
Temporal bone computed tomography (CT) scans or cone
beam CTs were retrospectively analyzed for the presence of
semicircular canal dehiscence, enlarged vestibular aqueduct,
cochlea-facial nerve dehiscence, and other third window
syndromes [see introduction and (24)]. It has to be noted,
however, that the intention for performing the CT and cone
beam CT scans were solely for preoperative evaluation of the
bony anatomy prior to a possible surgery for tumor removal
and hearing rehabilitation with a cochlear implant. They were
performed after the diagnosis of an ILS was established by MRI
and thus they usually did not include specific reconstructions for
evaluation of “third windows” of the inner ear, e.g., no planes
along the superior semicircular canal.
The patients’ medical histories taken at initial presentation
including audiological and vestibular complaints were
retrospectively evaluated for typical symptoms of third
window lesions including vertigo or oscillopsia induced by
loud sounds/Tullio phenomenon, increased sensitivity to low
frequency sounds, autophony, and pulsating tinnitus.
Data Analysis
A VEMP was ultimately judged as present, when the putative
response was clearly larger than the pre-stimulus waveforms,
i.e., the background noise. The impact of muscle contraction
on cVEMP results was reduced by averaging the root mean
square of the EMG signal over the pre-stimulus window and for
each recording frame to calculate the background EMG, i.e., the
contraction strength.
The p13 n23 for cVEMPs and n10 p15 for oVEMPs were
identified and peak latencies as well as peak-to-peak amplitudes
were recorded. The p13 n23 peak-to-peak amplitude was
normalized to the background EMG. The asymmetry ratio (AR)
was calculated from the peak-to-peak amplitudes. In order to
account for the side affected by the tumor (AS) and the non-
affected side (NAS) and to overcome the drawback of absolute
AR, a signed AR was used:
AR (%) =
amplitude (AS) − amplitude (NAS)
amplitude (AS) + amplitude (NAS)
∗100.
For cVEMPs, the AS refers to the response recorded from the
ipsilateral sternocleidomastoid muscle and for oVEMPs the AS
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refers to the response recorded from the contralateral inferior
oblique muscle. For cVEMPs, ARs above 30% or below −30%
were considered abnormal (49). For oVEMPs, abnormal ARs
were above 40% or below −40% (50, 51). Positive values of
the AR indicate larger responses of the affected ear (enhanced),
while negative values indicate smaller responses of the affected
ear (reduced), respectively. If no response could be detected, the
amplitude was set to 0 µV. For unilateral responses, the AR was
therefore 100% or−100%.
VEMP analysis was performed by two blinded examiners.
Normal distribution of the amplitude and latency data was
confirmed by a Shapiro-Wilk test. The intraclass correlation
coefficient [ICC (3, 1)] was calculated for the oVEMP and
cVEMP ARs based on the analysis by the two examiners to assess
the inter-rater reliability. If no responses could be detected on
the AS and NAS, the AR was set to 0% for the statistical test
(see following paragraph). Inter-rater agreement was considered
“poor” for ICCs below 0.50, “moderate” between 0.50 and 0.75,
“good” between 0.75 and 0.90, and “excellent” above 0.90 (52).
Good or excellent agreement was considered acceptable for
further analysis. The final latencies and amplitudes were the
averages of the examiners. For absence of a response rated by one
examiner but presence of a response rated by the other examiner,
the amplitudes were the averages and the latencies were taken
from the one examiner who rated the response to be present. The
cVEMP and oVEMP latencies and amplitudes recorded from the
AS were compared to the responses from the NAS as control by
paired t-tests. A confidence level of 95% or above was considered
to be significant (p < 0.05). SPSS statistics (IBM, Armonk, New
York, USA) was used for all statistical analyses.
The VEMP results were related to tumor localization in a
hypotheses generating descriptive analysis.
RESULTS
Twenty-six patients with solely intracochlear schwannoma (ICS)
were identified. Six patients had not undergone VEMP testing
and were therefore excluded. The analysis of the CTs or cone
beam CTs (available in 16 patients) revealed a dehiscent superior
semicircular canal in one case. This patient was excluded as well.
There were no signs for other third mobile windows of the otic
capsule. Thus, 19 patients with ICS were included in the study
for final analyis. Of those, 10 patients were male, 9 were female.
The mean age was 57.1 (SD: 13.4) years. In 8 patients, the left
ear was affected, in 11 patients the tumor was located in the
right ear. The mean hearing threshold [pure tone average at
0.5, 1, 2, and 4 kHz (4PTA)] was 90.8 (SD: 25.0) dB HL for the
affected side (AS) and 18.7 (SD:13.3) dB HL for the non-affected
side (NAS). Some of the patients reported pulsating tinnitus and
very few patients reported autophony and increased sensitivity
for low frequency sounds. Other typical clinical symptoms of
third window lesions like oscillopsia or vertigo induced by loud
sounds/Tullio phenomenon have not been observed in any of
those patients.
Despite the different image resolution of the MRIs, it was
possible to specify tumor localization according to basal turn
(BT), middle turn (MT), and the apex (apical turn, AT) in all
patients. Only in one patient, it was difficult to localize the tumor
with respect to the scala tympani (ST), and/or scala vestibuli (SV).
Data for all patients are summarized in Table 1. The tumor was
located in the BT in 2 patients (11%), in the MT in 7 patients
(37%), and in the AT in 1 patient (5%). In 4 patients (21%), the
tumor was in the BT and MT, in 4 patients (21%) it was in the
MT and AT, and in 1 patient (5%) it was in the BT, MT, and AT.
With respect to the scalae, tumors were observed solely in ST in 5
patients (26%). In no patient, the tumor was solely located in SV,
and in 14 patients (74%) it was located in both, ST, and SV.
Regarding the VEMP analysis, the inter-rater reliability
analysis by ICC revealed good to excellent agreement between the
two raters. For cVEMPs, the single measure ICC was 0.990 with
a 95% confidence interval from 0.996 to 0.975 [F(18) = 205.248,
p < 0.001]. For oVEMPs, the single measure ICC was 0.875 with
a 95% confidence interval from 0.706 to 0.950 [F(18) = 15.052, p
< 0.001]. Cervical VEMPs could be recorded from the affected
side (AS) in 13 cases (68%). In 4 cases, the response was absent in
the non-affected side (NAS) as well. In the other 2 cases, the AS
was the only ear without a response (AR=−100%). The oVEMP
measurements showed responses of the AS in 10 patients (53%).
In 6 cases, it was absent in both, AS and NAS. In 3 cases, the AS
was the only side without a response (AR = −100%). The mean
p13 n23 cVEMP amplitude was 0.46 (SD: 0.52) for the AS and
0.50 (SD: 0.45) for the NAS. For oVEMPs, the mean n10 p15
amplitude was 2.44 µV (SD: 4.27 µV) for the AS and 1.89 µV
(SD: 2.10 µV) for the NAS. The mean cVEMP p13 latencies were
16.5ms (SD: 1.8ms) for the AS and 16.1ms (SD: 1.7ms) for the
NAS, mean n23 latencies were 26.1ms (SD: 2.9ms) and 25.6ms
(SD: 2.2ms), respectively. For oVEMPs, the mean n10 latencies
were 12.7ms (SD: 1.0ms) for the AS and 12.4ms (SD: 0.8ms)
for the NAS, and p15 latencies were 18.1ms (SD: 1.3ms) and
17.9ms (SD: 1.2ms), respectively. Between the AS and NAS, no
significant difference was found for p13 and n23 cVEMP latencies
[t(12) = 1.267, p = 0.229; t(12) = 1.216, p = 0.247] as well as for
the n10 and p15 oVEMP latencies [t(9) = 1.552, p= 0.155; t(9) =
0.998, p= 0.344]. The results are illustrated in Figure 1A.
The VEMP asymmetry ratio (AR) results are given for each
patient in Table 1. Figure 1B illustrates the results in a boxplot.
Patients are color coded as they contribute to both the oVEMP
and cVEMP AR data. If no response could be recorded on both
the AS and NAS, the AR was illustrated at 0% by an empty circle
in the plot. The mean AR was −15.6% (SD: 53.6%) for cVEMPs
and −15.3% (SD: 64.5%) for oVEMPs. For cVEMPs, the AR was
smaller than −30%, i.e., asymmetrical with reduced responses
on the AS, in 5 cases (26%), including the 2 cases with ARs of
−100%. The AR was larger than 30%, i.e., asymmetrical with
enhanced responses in the AS, in 4 cases (21%). Including the
3 cases with ARs of −100%, the oVEMP AR was smaller than
−40% in 4 cases (21%) and larger than 40% in 3 cases (16%). In
total, VEMPs were enhanced on the AS in 5 patients: in 2 patients
only the cVEMPs (#8, #19), in 1 patient only the oVEMPs (#16),
and in 2 patients both, the cVEMPs and oVEMPs (#13, #14). The
VEMP results of these patients are illustrated in Figure 2.
CT or cone beam CT scans were available in four of five
patients with enhanced VEMPs (patient #8 declined the CT)
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TABLE 1 | Demographic data, oVEMP and cVEMP asymmetry ratio (AR) results, and tumor localization of included patients.
ID Age range AS 4PTA hearing level (dB) VEMP AR (%) ICS Location
AS NAS cVEMP oVEMP Cochlear turn Scala
1 45–50 R 75.00 16.25 n.a. −2 (MT)+AT ST+SV
2 45–50 R >110.00 6.25 −87* n.a. (BT)+MT+AT ST+SV
3 50–55 L 73.75 10.00 6 −29 (MT)+AT ST+SV
4 30–31 L 97.50 2.50 −63* n.a. (BT) ST+SV
5 65–70 R 80.00 28.75 −9 19 (BT)+MT ST
6 70–75 L >110.00 22.50 −65* −100* BT+(MT) ST
7 75–80 L >110.00 62.50 n.a. n.a. (MT) ST+SV
8 55–60 R >101.25 33.75 38* 7 MT ST+SV
9 55–60 R 97.5 11.25 12 n.a. AT ST+SV
10 70–75 R >110.00 18.75 −100* −85* MT ST+SV
11 70–75 L >110.00 23.75 −100* n.a. (MT)+(AT) ST+SV
12 60–65 R 86.25 8.75 8 −100* (MT) ST
13 30–35 L 71.25 8.75 59* 76* (MT) ST+SV
14 50–55 R 67.50 13.75 38* 67* (BT)+MT ST+SV
15 60–65 R >110.00 15.00 −16 −14 MT ST
16 65–70 R >110.00 10.00 n.a. 63* MT+AT ST+SV
17 60–65 L 91.25 21.25 12 −1 MT ST
18 40–45 L >110.00 23.75 n.a. −100* BT ST+SV
19 55–60 R 92.50 17.50 33* n.a. BT+(MT) ST+SV
4PTA, pure tone average at 0.5, 1, 3, 4 kHz; AS, affected side; NAS, non-affected side; AR, asymmetry ratio; ICS, intracochlear schwannoma; BT, basal turn; MT, middle turn; AT, apical
turn; ST, scala tumpani; SV, scala vestibuli; (), partially; *abnormal AR.
and did not show any signs of a third mobile window of the
otic capsule.
The analysis of enhanced VEMPs and tumor localization
showed that in 2 of the 5 patients with enhanced VEMPs only the
MT (#8, #13), in 2 patients the BT and MT (#14, #19), and in 1
patientMT andAT (#16) was involved. A correlation of enhanced
VEMPs and tumor localization with respect to the cochlear turn
could therefore not be observed. With respect to the scala, the
tumors were located in both, ST and SV, in all five patients with
enhanced VEMPs and in none of the patients where only the ST
was affected by the tumor.
DISCUSSION
Only a few studies reported VEMP results in patients with
intralabyrinthine schwannoma (ILS) andmostly described absent
or decreased cVEMPs and/or oVEMPs in these patients (6, 11,
12). The exact tumor localization and description of VEMP
results in patients with solely intracochlear schwannomas (ICS)
was done by Dubernard et al. (6) for 12 patients. Cervical
VEMPs were absent or significantly reduced in 50% of the
patients and “preserved” in the remaining 50%. Patients with
intravestibular tumors were also examined in their study and
were—not surprisingly—found to have a higher rate of absent or
reduced cVEMPs, which is likely due to a direct impact of the
tumor mass on the otolith organs. The results from our study are
the first to systematically analyze both oVEMPs and cVEMPs in
a series of cases with solely intracochlear tumors.
Despite the intracochlear position, the tumor affected the
vestibular response which was found to be absent, reduced and in
some cases enhanced. We observed absent or reduced cVEMPs
in 47% of the patients and normal cVEMPs in 32%. This is in line
with the results described by Dubernard et al. (6). The surprising
result was that the cVEMPs were enhanced in 21% of the patients
in our study. Ocular VEMPs were reduced or absent in 53% and
normal in 32%. Enhanced oVEMPs were observed in 15% of
the patients.
Many factors can cause reduced or absent VEMP responses.
Particularly in central pathology, the VEMPs are absent,
reduced and/or prolonged which can be an early indicator
of pathology (53–56). Many studies reported reduced or
absent VEMPs in patients with cochleovestibular schwannoma
(i.e., vestibular schwannoma, see introduction) and reported
a strong relationship with tumor size (57). Cervical VEMPs
in 38 ears of Neurofibromatosis Type 2 patients with small
cochleovestibular schwannomas were described by Holliday
et al. (58). Normal results were found in 71% and abnormal
cVEMPs were found in 29% of the patients with a correlation
between abnormal cVEMPs and tumor size. VEMP asymmetry
ratios (ARs) in patients with cochleovestibular schwannomas
can also be used as a screening tool for assessing the
function of the superior and inferior vestibular nerves before
and after surgical intervention (10). VEMP abnormalities in
these patients are attributed to compressional and neurotoxic
effects on the nerve and reduced vascular supply of the
labyrinth. However, retrocochlear pathology or direct impact
of the tumor on the otoliths was excluded in our study by
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FIGURE 1 | Latency and VEMP asymmetry ratio (AR) results of the included patients (n = 19). (A) Response latencies with means and standard deviations for the
cVEMP p13 and n23 for the side affected by the tumor (AS) (n = 13) and the non-affected side (NAS) (n = 16) as well as oVEMP n10 and p15 latencies for the AS
(n = 10) and NAS (n = 13). No significant differences were found between latencies of the AS and NAS. (B) Signed ARs for cVEMPs and oVEMPs with means and
standard deviations. Patients are color coded as they contribute to both the oVEMP and cVEMP AR data. Negative values indicate larger responses on the NAS,
positive values indicate larger responses on the AS. For cVEMPs, ARs exceeding ±30% were considered abnormal. For oVEMPs, abnormal ARs were larger/smaller
than ±40%. The limits are illustrated by horizontal dashed lines. Data points above the thresholds represent enhanced VEMPs with respect to the AS, data points
below the thresholds represent reduced VEMPs in the AS. Patients with absent responses on the AS are shown at AR = −100%. For patients with absent responses
on both AS and NAS, the ARs are illustrated at AR = 0% as empty circles.
including only patients with solely intracochlear tumors. In
addition, another patient with superior canal dehiscence was
excluded, which could have acted as a confounding factor in
the VEMP analysis. The pathophysiology of ICS leading to
abnormal VEMPs is unknown and can only be speculated
about. In patients with cochleovestibular schwannomas (without
intracochlear localization of tumors), it has been reported
that sensorineural hearing loss is associated with tumor-
secreted factors containing pro-inflammatory cytokines which
cause cochlear damage (59, 60). This could explain why large
cochleovestibular schwannomas sometimes do not cause hearing
loss while small ones do. This has not been investigated yet for
ICS associated loss of otolith function but could be a similar
mechanism. Possibly, the finding of reduced or absent VEMPs
in these patients is attributed to a local cytotoxic effect conveyed
by the labyrinthine fluids (6).
In the present study, the major and unexpected finding was
that the VEMPs in ICS in some patients were enhanced but
no latency prolongation was observed. Enhanced VEMPs are
commonly seen in patients with third window syndrome. Thus,
VEMPs have become a widely used tool in the diagnosis of third
window syndrome (16, 24, 29–33) and are enhanced in those
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FIGURE 2 | Results of patients with enhanced VEMPs. The black trace shows the response of the affected side (AS), the response from the non-affected side (NAS) is
shown by the gray line. The p13, n23 peaks for cVEMPs and n10, p15 peaks for oVEMPs are marked. The MRI scans are shown in the right column with the tumors
marked by white arrows. Patient #8, #13, #19: axial, Patient #14 and #16: coronal; R, right; L, left; T1+CM, t1-weighted with contrast medium; T2, t2-weighted.
ears with a defect in the otic capsule (25–28). However, other
conditions with endolymphatic hydrops such asMenière’s disease
have been shown to mimic third window syndrome showing
reduced VEMP thresholds and enhanced amplitudes (44–47).
To date, it was unknown that—with respect to VEMP results—
other inner ear disorders, ICS in particular, have the potential
to mimic third window syndrome as well. In our experience,
management of patients with ILS is highly individual and detailed
functional evaluation of the vestibular labyrinth is important for
counseling these patients regarding treatment options (especially
with respect to surgical tumor removal) and outcome predictions
(61, 62).
To explain the cause of enhanced VEMP amplitudes in ICS
patients, we assume that this is due to a change of inner
ear (fluid) mechanics caused by the tumor. In this study,
we only included ICS patients to avoid bias due to direct
influence of the tumor on the otoliths (e.g., as in intravestibular
or intravestibulocochlear schwannomas) or by tumor in the
internal auditory canal. Measurements, models, and animal
studies have shown that in patients with superior semicircular
canal dehiscence, a third mobile window leads to larger fluid
displacement in the semicircular canals which activates canal
neurons contributing to the VEMP and enhancing it (34, 37, 63).
This shows that mechanical changes cause enhanced VEMPs.
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It also supports the theory that mechanical changes can lead
to enhanced VEMPs in patients with endolymphatic hydrops.
The exact mechanisms of this observation are yet unknown.
Endolymphatic hydrops can have various causes (39, 40). It seems
possible that an obstructive tumor mass like an ICS has the
potential to cause or act similar to endolymphatic hydrops. This
idea is supported by the observation in our study that cVEMPs
or oVEMPs were only enhanced, if both scala tympani (ST) and
scala vestibuli (SV) were “blocked” by the tumor. This leads
to the somehow contradictory observation that—with respect
to VEMPs—a “third window syndrome” can act similar to a
“minus 1 window syndrome” or “one window syndrome,” when
the cochlear is “blocked” by a tumor.
In such situations, acoustic stimulation cannot lead to a fully
developed traveling wave within the cochlea. Nevertheless, the
stapes displacement must still be compensated by a reciprocal
displacement of the round window membrane. It is conceivable
that this may lead to a perilymph flow which is oscillating more
or less directly between the oval window and the round window
including a corresponding displacement of the basal basilar
membrane. Clearly, in this configuration the fluid dynamics in
the basal region of the cochlea would be significantly altered
and—similar to the third window syndrome (36)—there would
be higher flow velocities close to the saccule which may lead
to enhanced VEMPs. It appears also possible that the cochlear
blockage leads to a suppression of the piston-like stapes motion
(PSM) and that the acoustic stimulation leads only to a “rocking
stapes motion” (RSM) which does not create any net fluid
displacement within the otic capsule. It has been shown [Figure
5 in Edom et al. (64)] that RSM leads to significantly increased
perilymph flow in the basal region of the cochlea whichmay affect
saccular stimulation and be connected to enhanced VEMPs.
Computer-modeling of the fluid dynamics of a “blocked” cochlea
may have the potential to give answers to the question if the
mass effect without concomitant neural damage could cause
the enhancement of VEMPs and should be considered in
future studies.
Limitations of the study include its retrospective design,
which is due to the nature of the observation which was
more or less accidental. This is also a reason, why the study
did not include threshold measurements. Since VEMPs evoked
by bone conducted vibration were not available at that time,
only air conduction was used for stimulation. While any third
window abnormalities were excluded in most patients, CT
scans were not available in 1 of the 5 patients with enhanced
VEMPs, and CTs (although thin-sliced) were technically not
targeted specifically on exclusion of bony defects of the inner
ear. These limitations can be addressed in further studies
including specific history taking (i.e., checklists for symptoms
of third window syndromes), threshold measurements in all
patients with enhanced VEMPs as well as specific CT scans in
these patients. Another aspect which has to be considered in
further studies is the evolution of VEMPs in these patients. It
should be examined, how the VEMP amplitudes and latencies
change over time, possibly in the course of tumor growth.
Regarding the different outcomes, i.e., especially reduced or
absent in contrast to normal or enhanced VEMPs, the tumors’
intrinsic biology with respect to tumor secreted factors should
be investigated as was done for cochleovestibular schwannomas
causing hearing loss (59, 60). This is important to assess
the clinical relevance of normal, absent or reduced, and
enhanced VEMPs and might become beneficial for counseling
ICS patients.
CONCLUSION
We described that enhanced VEMP amplitudes could be
observed in patients with intracochlear schwannoma. It was
an unexpected novelty that in addition to conditions described
by the general term of the third window syndrome, or in
Menière’s disease, VEMP amplitudes can be enhanced in patients
with intracochlear schwannoma. Response latencies were not
significantly different between the side affected by the tumor and
the non-affected side. Intracochlear tumors should therefore be
added to the list of conditions which may cause increased VEMP
amplitudes. Since management of patients with intracochlear
schwannomas is highly individual, these findings might become
beneficial for counseling these patients regarding treatment
options and outcome predictions.
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